Akorn Pharmaceuticals, a medical device maker that specializes in cardiac stimulators, was one of the first companies to announce a drug that could treat patients with ventricular fibrillation.Akhorn has now raised a $6 billion round led by Google Ventures.It also raised another $1 billion in Series B funding.The company’s CEO, Peter Akorn, said in a […]

Continue Reading...